Michelle Robertson

2018 - Momenta Pharmaceuticals

In 2018, Michelle Robertson earned a total compensation of $1.2M as Chief Financial Officer at Momenta Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$147,000
Salary$301,395
Stock Awards$747,662
Other$13,516
Total$1,209,573

Robertson received $747.7K in stock awards, accounting for 62% of the total pay in 2018.

Robertson also received $147K in non-equity incentive plan, $301.4K in salary and $13.5K in other compensation.

Rankings

In 2018, Michelle Robertson's compensation ranked 8,251st out of 14,244 executives tracked by ExecPay. In other words, Robertson earned more than 42.1% of executives.

ClassificationRankingPercentile
All
8,251
out of 14,244
42nd
Division
Manufacturing
3,262
out of 5,765
43rd
Major group
Chemicals And Allied Products
1,222
out of 2,128
43rd
Industry group
Drugs
1,022
out of 1,817
44th
Industry
Biological Products, Except Diagnostic Substances
194
out of 339
43rd

Pay ratio

Michelle Robertson's Pay$1,209,573
Median Employee's Pay$175,536
Pay Ratio

7

to 1

In 2018, the annual total compensation of Michelle Robertson was $1,209,573.

The annual total compensation of the median employee at Momenta Pharmaceuticals was $175,536.

The ratio of Michelle Robertson's pay to the pay of median employee was therefore 7 to one.

Source: SEC filing on April 26, 2019.

Robertson's colleagues

We found five more compensation records of executives who worked with Michelle Robertson at Momenta Pharmaceuticals in 2018.

2018

Craig Wheeler

Momenta Pharmaceuticals

Chief Executive Officer

2018

Young Kwon

Momenta Pharmaceuticals

Chief Business Officer

2018

Santiago Arroyo

Momenta Pharmaceuticals

Chief Medical Officer

2018

Anthony Manning

Momenta Pharmaceuticals

Chief Scientific Officer

2018

Scott Storer

Momenta Pharmaceuticals

Chief Financial Officer

News

You may also like